Invesco’s West Pharmaceutical WST Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $265M | Buy |
1,056,007
+147,382
| +16% | +$36.7M | 0.03% | 589 |
|
|
2025
Q4 | $250M | Buy |
908,625
+27,340
| +3% | +$7.48M | 0.02% | 588 |
|
|
2025
Q3 | $231M | Sell |
881,285
-78,240
| -8% | -$19M | 0.04% | 608 |
|
|
2025
Q2 | $210M | Buy |
959,525
+10,070
| +1% | +$2.15M | 0.04% | 614 |
|
|
2025
Q1 | $213M | Buy |
949,455
+194,216
| +26% | +$53.5M | 0.04% | 592 |
|
|
2024
Q4 | $247M | Buy |
755,239
+7,876
| +1% | +$2.48M | 0.05% | 531 |
|
|
2024
Q3 | $224M | Buy |
747,363
+130,180
| +21% | +$39.9M | 0.04% | 564 |
|
|
2024
Q2 | $203M | Sell |
617,183
-147,496
| -19% | -$52.1M | 0.04% | 561 |
|
|
2024
Q1 | $303M | Sell |
764,679
-177,990
| -19% | -$65.8M | 0.07% | 417 |
|
|
2023
Q4 | $332M | Buy |
942,669
+161,904
| +21% | +$57.3M | 0.08% | 344 |
|
|
2023
Q3 | $293M | Sell |
780,765
-206,810
| -21% | -$80M | 0.08% | 340 |
|
|
2023
Q2 | $378M | Sell |
987,575
-160,094
| -14% | -$57.2M | 0.1% | 259 |
|
|
2023
Q1 | $398M | Buy |
1,147,669
+543,382
| +90% | +$159M | 0.11% | 224 |
|
|
2022
Q4 | $142M | Sell |
604,287
-67,882
| -10% | -$16.1M | 0.04% | 582 |
|
|
2022
Q3 | $165M | Sell |
672,169
-184,204
| -22% | -$56.1M | 0.05% | 481 |
|
|
2022
Q2 | $259M | Sell |
856,373
-148,975
| -15% | -$48.5M | 0.08% | 340 |
|
|
2022
Q1 | $413M | Sell |
1,005,348
-79,759
| -7% | -$31.2M | 0.11% | 243 |
|
|
2021
Q4 | $509M | Sell |
1,085,107
-174,992
| -14% | -$75.3M | 0.12% | 190 |
|
|
2021
Q3 | $535M | Buy |
1,260,099
+154,534
| +14% | +$65.1M | 0.14% | 173 |
|
|
2021
Q2 | $397M | Sell |
1,105,565
-407,307
| -27% | -$135M | 0.1% | 260 |
|
|
2021
Q1 | $426M | Sell |
1,512,872
-213,034
| -12% | -$61M | 0.11% | 213 |
|
|
2020
Q4 | $489M | Buy |
1,725,906
+190,274
| +12% | +$53.4M | 0.14% | 164 |
|
|
2020
Q3 | $422M | Buy |
1,535,632
+462,972
| +43% | +$123M | 0.14% | 155 |
|
|
2020
Q2 | $244M | Buy |
1,072,660
+199,301
| +23% | +$39.2M | 0.09% | 271 |
|
|
2020
Q1 | $133M | Buy |
873,359
+37,651
| +5% | +$5.8M | 0.06% | 404 |
|
|
2019
Q4 | $126M | Buy |
835,708
+128,010
| +18% | +$18.6M | 0.04% | 563 |
|
|
2019
Q3 | $100M | Buy |
707,698
+109,911
| +18% | +$15.1M | 0.03% | 659 |
|
|
2019
Q2 | $74.8M | Buy |
597,787
+239,545
| +67% | +$28.3M | 0.02% | 821 |
|
|
2019
Q1 | $39.5M | Buy |
358,242
+30,327
| +9% | +$3.15M | 0.01% | 921 |
|
|
2018
Q4 | $32.1M | Buy |
327,915
+278,455
| +563% | +$30.2M | 0.01% | 937 |
|
|
2018
Q3 | $6.11M | Buy |
49,460
+67
| +0.1% | +$7.51K | ﹤0.01% | 2031 |
|
|
2018
Q2 | $4.9M | Sell |
49,393
-306,002
| -86% | -$28.2M | ﹤0.01% | 2151 |
|
|
2018
Q1 | $31.4M | Buy |
355,395
+5,948
| +2% | +$556K | 0.01% | 944 |
|
|
2017
Q4 | $34.5M | Buy |
349,447
+757
| +0.2% | +$74.2K | 0.01% | 935 |
|
|
2017
Q3 | $33.6M | Buy |
348,690
+3,306
| +1% | +$299K | 0.01% | 940 |
|
|
2017
Q2 | $32.6M | Sell |
345,384
-15,222
| -4% | -$1.4M | 0.01% | 971 |
|
|
2017
Q1 | $29.4M | Sell |
360,606
-39,928
| -10% | -$3.34M | 0.01% | 1025 |
|
|
2016
Q4 | $34M | Sell |
400,534
-111,343
| -22% | -$8.76M | 0.01% | 962 |
|
|
2016
Q3 | $38.1M | Buy |
511,877
+119,341
| +30% | +$9.47M | 0.01% | 896 |
|
|
2016
Q2 | $29.8M | Sell |
392,536
-11,960
| -3% | -$870K | 0.01% | 995 |
|
|
2016
Q1 | $28M | Sell |
404,496
-153,905
| -28% | -$9.26M | 0.01% | 998 |
|
|
2015
Q4 | $33.6M | Buy |
558,401
+49,104
| +10% | +$2.95M | 0.01% | 928 |
|
|
2015
Q3 | $27.6M | Buy |
509,297
+153,790
| +43% | +$8.96M | 0.01% | 999 |
|
|
2015
Q2 | $20.6M | Buy |
355,507
+111,002
| +45% | +$6.2M | 0.01% | 1204 |
|
|
2015
Q1 | $14.7M | Buy |
244,505
+33,601
| +16% | +$1.79M | 0.01% | 1359 |
|
|
2014
Q4 | $11.2M | Buy |
210,904
+22,214
| +12% | +$1.11M | ﹤0.01% | 1487 |
|
|
2014
Q3 | $8.45M | Sell |
188,690
-12,215
| -6% | -$519K | ﹤0.01% | 1621 |
|
|
2014
Q2 | $8.47M | Sell |
200,905
-818,408
| -80% | -$35M | ﹤0.01% | 1630 |
|
|
2014
Q1 | $44.9M | Buy |
1,019,313
+10,125
| +1% | +$477K | 0.02% | 834 |
|
|
2013
Q4 | $49.5M | Buy |
1,009,188
+27,083
| +3% | +$1.27M | 0.02% | 803 |
|
|
2013
Q3 | $40.4M | Buy |
982,105
+110,151
| +13% | +$4.2M | 0.02% | 867 |
|
|
2013
Q2 | $30.6M | Buy |
+871,954
| New | +$28.7M | 0.01% | 945 |
|
Other funds holding WST
VCM
VPM
GIM
Invesco's WST Position: Q1 2026 in Review
Invesco increased its West Pharmaceutical (WST) stake by 16% in Q1 2026, buying an estimated $36.7M and bringing the position to 1,056,007 shares worth $265M. The position accounts for 0.03% of the portfolio, ranked #589.
Invesco first reported a position in WST in Q2 2013 and has held it in 52 quarters since. The position peaked at $535M in Q3 2021. 753 funds tracked by Wall St. Rank hold WST as of Q1 2026.
- Invesco held 1,056,007 shares of West Pharmaceutical worth $265M as of Q1 2026.
- Invesco bought 147,382 West Pharmaceutical shares in Q1 2026, an estimated $36.7M.
- West Pharmaceutical made up 0.03% of Invesco's portfolio in Q1 2026, its #589 holding.
- Invesco first reported a position in West Pharmaceutical in Q2 2013 and has held it in 52 quarters since.
- Invesco's West Pharmaceutical position peaked at $535M in Q3 2021.
- 753 funds tracked by Wall St. Rank held West Pharmaceutical as of Q1 2026.
Based on Invesco's 13F filing for Q1 2026, filed 12 May 2026.